Perineural Dexmedetomidine for Ulnar Nerve Block.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03222323|
Recruitment Status : Unknown
Verified July 2017 by Jakob Hessel Andersen, Zealand University Hospital.
Recruitment status was: Recruiting
First Posted : July 19, 2017
Last Update Posted : July 31, 2017
Zealand University Hospital
Information provided by (Responsible Party):
Jakob Hessel Andersen, Zealand University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||January 1, 2018|
|Estimated Study Completion Date :||April 1, 2018|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Andersen JH, Jaeger P, Grevstad U, Estrup S, Geisler A, Vilhelmsen F, Dahl JB, Laier GH, Ilfeld BM, Mathiesen O. Systemic dexmedetomidine is not as efficient as perineural dexmedetomidine in prolonging an ulnar nerve block. Reg Anesth Pain Med. 2019 Mar;44(3):333-340. doi: 10.1136/rapm-2018-100089. Epub 2019 Jan 23.